Posts with tag: travel
US stocks rallied on Tuesday as investors gauged China's immediate response to President Donald Trump's additional tariffs amidst fears of a potential trade war. Investors also digested fresh jobs data, with job openings dropping more than expected in December. Investors continue to monitor signs of a cooling labor market as the Federal Reserve weighs future interest rate cuts amid persistent inflation.
Published on: February 04, 2025, 08:00 PM UTC
Why is Atkore (ATKR) stock down 21%? Q4 results missed expectations, with revenue and EBITDA falling short. However, EPS beat estimates. Is now the time to buy?
Published on: February 04, 2025, 07:03 PM UTC
Meta shares rise after a solid earnings report and optimism about AI-related growth opportunities. Technical analysis suggests short-term bullish targets around $755 and longer-term targets around $935. Key support levels to monitor on pullbacks are $632 and $600.
Published on: February 04, 2025, 07:01 PM UTC
Meta's CTO anticipated the launch of DeepSeek's AI model months ago, calling it "both a big deal and also not as big as it's made out to be."
Published on: February 04, 2025, 07:01 PM UTC
J&J Snack Foods (JJSF) shares dropped 11.1% premarket after the company reported underwhelming Q4 results. Gross margin missed estimates, leading to an EPS shortfall. Read more on JJSF's performance and market impact.
Published on: February 04, 2025, 06:04 PM UTC
Pfizer (PFE) reports Q4 and full-year 2024 earnings, beating Wall Street expectations. Revenue grew 7% to $63.6 billion for the year, while EPS of $3.12 exceeded estimates. Despite facing headwinds like pipeline challenges and Medicare price negotiations, Pfizer plans to cut costs and enhance shareholder value in 2025.
Published on: February 04, 2025, 06:03 PM UTC
Fox to Enter Competitive Streaming Marketplace, Target Cord-Cutters
Published on: February 04, 2025, 06:02 PM UTC
Daily newsletter tracking global trade: US-China trade war updates, including tariffs, investigations, and potential deal contours.
Published on: February 04, 2025, 05:04 PM UTC
Pfizer's Q4 2024 earnings beat expectations, with revenue up 7% YoY to $63.6B and EPS of $3.12 exceeding estimates. The company is downsizing to offset waning COVID-19 product revenue, targeting $4.5B in savings by 2025. Despite headwinds such as patent expirations and Medicare price negotiations, Pfizer aims to enhance shareholder value through R&D productivity and strategic priorities.
Published on: February 04, 2025, 05:03 PM UTC
Implementing a top-tier forwarder TMS can significantly enhance any freight forwarder’s logistics operations. Choosing a scalable TMS that can meet the specific needs of each client is crucial, and Descartes provides the customer support to ensure TMS users always have the training and solutions they need.
Published on: February 04, 2025, 05:00 PM UTC